Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pharmaceutical Asset Performance Management (APM) Market by Type (Asset Integrity Management, Asset Reliability Management, Other), By Application (Large Enterprises, SMEs, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pharmaceutical Asset Performance Management (APM) Market by Type (Asset Integrity Management, Asset Reliability Management, Other), By Application (Large Enterprises, SMEs, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 173656 3300 IT & Telecom 377 237 Pages 4.8 (31)
                                          

The global pharmaceutical asset performance management (APM) market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The APM market is segmented on the basis of type, application, and region. The asset integrity management segment accounted for the largest share in the APM market in 2018 and is expected to continue its dominance throughout the forecast period. Asset reliability management accounted for a significant share in 2018 and is expected to grow at a CAGR of 8% during the forecast period. Large enterprises are projected to account for more than 50% of total revenue generated by APM solutions providers by 2030 end. North America was estimated as leading region with respect to revenue generation in 2018 and it will continue its dominance throughout the forecast period with an estimated CAGR of 8%.

Some Of The Growth Factors Of This Market:

  1. The pharmaceutical industry is one of the most profitable industries in the world, with a global market size of $1 trillion.
  2. Pharmaceutical companies are increasingly investing in R&D to develop new drugs and treatments for diseases such as cancer, diabetes, Alzheimer's disease, and Parkinson's disease.
  3. The aging population will also drive growth in the pharmaceutical industry as more people live longer due to improved healthcare standards.
  4. Increasing demand for generic drugs will also drive growth in the pharmaceutical industry.

Industry Growth Insights published a new data on “Pharmaceutical Asset Performance Management (APM) Market”. The research report is titled “Pharmaceutical Asset Performance Management (APM) Market research by Types (Asset Integrity Management, Asset Reliability Management, Other), By Applications (Large Enterprises, SMEs, ), By Players/Companies GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany), ”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Pharmaceutical Asset Performance Management (APM) Market Research Report

By Type

Asset Integrity Management, Asset Reliability Management, Other

By Application

Large Enterprises, SMEs,

By Companies

GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany),

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Pharmaceutical Asset Performance Management (APM) Industry Outlook


Global Pharmaceutical Asset Performance Management (APM) Market Report Segments:

The global Pharmaceutical Asset Performance Management (APM) market is segmented on the basis of:

Types

Asset Integrity Management, Asset Reliability Management, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Large Enterprises, SMEs,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GE (US)
  2. Rockwell Software (US)
  3. AVEVA Group plc (UK)
  4. Bentley Systems (US)
  5. AspenTech (US)
  6. Nexus Global (US)
  7. SAP (Germany)

Global Pharmaceutical Asset Performance Management (APM) Market Overview


Highlights of The Pharmaceutical Asset Performance Management (APM) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Asset Integrity Management
    2. Asset Reliability Management
    3. Other
  1. By Application:

    1. Large Enterprises
    2. SMEs
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pharmaceutical Asset Performance Management (APM) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pharmaceutical Asset Performance Management (APM) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


APM is a methodology for managing pharmaceutical assets and performance. It helps identify opportunities to improve the value of a company's pharmaceutical portfolio, and makes recommendations on how best to achieve those goals. APM also provides guidance on how to measure and track progress towards asset value objectives.

Some of the major companies in the pharmaceutical asset performance management (apm) market are GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany).

The pharmaceutical asset performance management (apm) market is expected to register a CAGR of 7.2%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Pharmaceutical Asset Performance Management (APM) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Pharmaceutical Asset Performance Management (APM) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Pharmaceutical Asset Performance Management (APM) Market - Supply Chain
   4.5. Global Pharmaceutical Asset Performance Management (APM) Market Forecast
      4.5.1. Pharmaceutical Asset Performance Management (APM) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Pharmaceutical Asset Performance Management (APM) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Pharmaceutical Asset Performance Management (APM) Market Absolute $ Opportunity

5. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
      5.3.1. Asset Integrity Management
      5.3.2. Asset Reliability Management
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      6.3.1. Large Enterprises
      6.3.2. SMEs
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026

9. North America Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      9.4.1. Large Enterprises
      9.4.2. SMEs
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
      9.7.1. Asset Integrity Management
      9.7.2. Asset Reliability Management
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026

10. Latin America Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      10.4.1. Large Enterprises
      10.4.2. SMEs
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
      10.7.1. Asset Integrity Management
      10.7.2. Asset Reliability Management
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026

11. Europe Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      11.4.1. Large Enterprises
      11.4.2. SMEs
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Pharmaceutical Asset Performance Management (AM) Market Size and Volume Forecast by Type
      11.7.1. Asset Integrity Management
      11.7.2. Asset Reliability Management
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026

12. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      12.4.1. Large Enterprises
      12.4.2. SMEs
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
      12.7.1. Asset Integrity Management
      12.7.2. Asset Reliability Management
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026

13. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
      13.4.1. Large Enterprises
      13.4.2. SMEs
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
      13.7.1. Asset Integrity Management
      13.7.2. Asset Reliability Management
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Pharmaceutical Asset Performance Management (APM) Market: Market Share Analysis
   14.2. Pharmaceutical Asset Performance Management (APM) Distributors and Customers
   14.3. Pharmaceutical Asset Performance Management (APM) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GE (US)
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Rockwell Software (US)
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. AVEVA Group plc (UK)
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Bentley Systems (US)
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. AspenTech (US)
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Nexus Global (US)
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. SAP (Germany)
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
          14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us